156 related articles for article (PubMed ID: 32682005)
1. Doxycycline decreases amyloidogenic light chain-induced autophagy in isolated primary cardiac myocytes.
Valero-Muñoz M; Wilson RM; Bretón-Romero R; Croteau D; Seldin DC; Sam F
Int J Cardiol; 2020 Dec; 321():133-136. PubMed ID: 32682005
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Biolo A; Ramamurthy S; Connors LH; O'Hara CJ; Meier-Ewert HK; Soo Hoo PT; Sawyer DB; Seldin DC; Sam F
Circ Heart Fail; 2008 Nov; 1(4):249-57. PubMed ID: 19808299
[TBL] [Abstract][Full Text] [Related]
3. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity.
Guan J; Mishra S; Qiu Y; Shi J; Trudeau K; Las G; Liesa M; Shirihai OS; Connors LH; Seldin DC; Falk RH; MacRae CA; Liao R
EMBO Mol Med; 2014 Nov; 6(11):1493-507. PubMed ID: 25319546
[TBL] [Abstract][Full Text] [Related]
4. Light Chain Amyloidosis-Induced Autophagy Is Mediated by the Foxo3a/Beclin-1 Pathway in Cardiomyocytes.
Zhang Y; Yu W; Chang W; Wang M; Zhang L; Yu F
Lab Invest; 2023 Feb; 103(2):100001. PubMed ID: 37039144
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline reduces fibril formation in a transgenic mouse model of AL amyloidosis.
Ward JE; Ren R; Toraldo G; Soohoo P; Guan J; O'Hara C; Jasuja R; Trinkaus-Randall V; Liao R; Connors LH; Seldin DC
Blood; 2011 Dec; 118(25):6610-7. PubMed ID: 21998211
[TBL] [Abstract][Full Text] [Related]
6. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity.
Guan J; Mishra S; Shi J; Plovie E; Qiu Y; Cao X; Gianni D; Jiang B; Del Monte F; Connors LH; Seldin DC; Lavatelli F; Rognoni P; Palladini G; Merlini G; Falk RH; Semigran MJ; Dec GW; Macrae CA; Liao R
Basic Res Cardiol; 2013 Sep; 108(5):378. PubMed ID: 23982491
[TBL] [Abstract][Full Text] [Related]
8. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
Imperlini E; Gnecchi M; Rognoni P; Sabidò E; Ciuffreda MC; Palladini G; Espadas G; Mancuso FM; Bozzola M; Malpasso G; Valentini V; Palladini G; Orrù S; Ferraro G; Milani P; Perlini S; Salvatore F; Merlini G; Lavatelli F
Sci Rep; 2017 Nov; 7(1):15661. PubMed ID: 29142197
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish model of amyloid light chain cardiotoxicity: regeneration versus degeneration.
Mishra S; Joshi S; Ward JE; Buys EP; Mishra D; Mishra D; Morgado I; Fisch S; Lavatelli F; Merlini G; Dorbala S; MacRae CA; Liao R
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1158-H1166. PubMed ID: 30875258
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline ameliorates aggregation of collagen and atrial natriuretic peptide in murine post-infarction heart.
Zhu H; Sun X; Wang D; Hu N; Zhang Y
Eur J Pharmacol; 2015 May; 754():66-72. PubMed ID: 25724785
[TBL] [Abstract][Full Text] [Related]
11. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.
Brenner DA; Jain M; Pimentel DR; Wang B; Connors LH; Skinner M; Apstein CS; Liao R
Circ Res; 2004 Apr; 94(8):1008-10. PubMed ID: 15044325
[TBL] [Abstract][Full Text] [Related]
12. Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis.
Lavatelli F; Imperlini E; Orrù S; Rognoni P; Sarnataro D; Palladini G; Malpasso G; Soriano ME; Di Fonzo A; Valentini V; Gnecchi M; Perlini S; Salvatore F; Merlini G
FASEB J; 2015 Nov; 29(11):4614-28. PubMed ID: 26220173
[TBL] [Abstract][Full Text] [Related]
13. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
Mishra S; Guan J; Plovie E; Seldin DC; Connors LH; Merlini G; Falk RH; MacRae CA; Liao R
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H95-103. PubMed ID: 23624626
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damage.
Lin Y; Marin-Argany M; Dick CJ; Redhage KR; Blancas-Mejia LM; Bulur P; Butler GW; Deeds MC; Madden BJ; Williams A; Wall JS; Dietz A; Ramirez-Alvarado M
Cytotherapy; 2017 Dec; 19(12):1426-1437. PubMed ID: 29037943
[TBL] [Abstract][Full Text] [Related]
15. Light chain amyloidosis induced inflammatory changes in cardiomyocytes and adipose-derived mesenchymal stromal cells.
Jordan TL; Maar K; Redhage KR; Misra P; Blancas-Mejia LM; Dick CJ; Wall JS; Williams A; Dietz AB; van Wijnen AJ; Lin Y; Ramirez-Alvarado M
Leukemia; 2020 May; 34(5):1383-1393. PubMed ID: 31796914
[TBL] [Abstract][Full Text] [Related]
16. Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.
Charitaki E; Kastritis E; Petraki C; Liapis K; Adamidis K; Apostolou T; Christodoulidou C; Nikolopoulou N; Terpos E; Nakopoulou L; Dimopoulos MA
Clin Nephrol; 2016 Jan; 85(1):44-54. PubMed ID: 26587779
[TBL] [Abstract][Full Text] [Related]
17. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts.
Liao R; Jain M; Teller P; Connors LH; Ngoy S; Skinner M; Falk RH; Apstein CS
Circulation; 2001 Oct; 104(14):1594-7. PubMed ID: 11581134
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis.
D'Souza A; Flynn K; Chhabra S; Dhakal B; Hamadani M; Jacobsen K; Pasquini M; Weihrauch D; Hari P
Contemp Clin Trials Commun; 2017 Dec; 8():33-38. PubMed ID: 29696194
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of amyloidogenic immunoglobulin light chains in cell culture.
Sikkink LA; Ramirez-Alvarado M
Cell Death Dis; 2010 Nov; 1(11):e98. PubMed ID: 21368874
[TBL] [Abstract][Full Text] [Related]
20. Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
Grogan M; Dispenzieri A; Gertz MA
Heart; 2017 Jul; 103(14):1065-1072. PubMed ID: 28456755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
